www.3sbio.com 提示:

本信息仅供医学专业人士参考,如果您是医学专业人士,请点击确定后进入。 如果不是,请点击取消。

取消 确定

Establishing a Solid Future for 3SBio through Transparent Management


3SBio Inc. (the “Company”) implements the following arrangements for electronic dissemination of Corporate Communications(Note 1) pursuant to Rule 2.07A(1) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and the articles of association of the Company:

Please note that, as of 6 March 2024, both the English and Chinese versions of the Company’s all future Corporate Communications will be available electronically on the website of the Company at www.3sbio.com and the HKExnews website at www.hkexnews.hk in place of printed copies.

● For registered shareholders, please refer to: Notification Letter to Registered Shareholders (with Reply Form)

● For Non-registered Holders(Note 2) , please refer to: Notification Letter to Non-registered Holders (with Reply Form)

Should you have any queries relating to this matter, please contact the the Company’s share registrar, Computershare Hong Kong Investor Services Limited, at (852) 2862 8688.


. 1. “Corporate Communications” refer to any documents issued or to be issued by the Company for the information or action of holders of any of its securities, including but not limited to (a) the directors' report, its annual accounts together with a copy of the auditor’s report and, where applicable, its summary financial report; (b) the interim report and, where applicable, its summary interim report; (c) a notice of meeting; (d) a listing document; (e) a circular; and (f) a proxy form.

. 2. “Non-registered Holder” means such person or company whose shares are held in The Central Clearing and Settlement System (CCASS) and who has notified the Company from time to time through Hong Kong Securities Clearing Company Limited that such person or company wishes to receive Corporate Communications.